OKSANA EVANS: Open Payments
NPI 1225579618 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,708 in 143 payments from 20 companies in 2025. Trend: 2023 $3,998 · 2024 $2,900 · 2025 $2,708
Food & beverage: $2,609Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $370 |
| GENZYME CORPORATION | 8 | $316 |
| UCB, Inc. | 16 | $272 |
| ABBVIE INC. | 16 | $255 |
| Regeneron Healthcare Solutions, Inc. | 12 | $242 |
| Novartis Pharmaceuticals Corporation | 16 | $168 |
| Galderma Laboratories, L.P. | 11 | $163 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $149 |
| Organon LLC | 10 | $142 |
| Arcutis Biotherapeutics, Inc. | 2 | $106 |
Products named: DUPIXENT, TREMFYA, Bimzelx, SKYRIZI, COSENTYX, Zoryve, CIBINQO, Winlevi.
Industry payments across FL — which companies pay providers there.
